PCYT2 and metabolic dysfunction-associated steatohepatitis: Hepatic inflammation is the critical factor distinguishing NASH from simple steatosis and is further demonstrated in adult Pcyt2+/− in the enrichment of proinflammatory pathways and increased mRNA/protein expression of proinflammatory modulators.